Becton Dickinson (BDX) Total Current Liabilities (2009 - 2026)
Becton Dickinson (BDX) posted quarterly Total Current Liabilities of $8.5 billion for Q1 2026, up 10.61% year-over-year from $7.7 billion in Q1 2025, and down 2.9% quarter-over-quarter from $8.8 billion in Q4 2025.
Becton Dickinson (BDX) Total Current Liabilities (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has reported Total Current Liabilities for 18 consecutive years, with $8.5 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities rose 10.61% year-over-year to $8.5 billion; the TTM figure through Mar 2026 stood at $8.5 billion (up 10.61% YoY), while the FY2025 annual figure was $8.3 billion, down 7.18% from the prior year.
- Total Current Liabilities eased to $8.5 billion in Q1 2026 per BDX's latest filing, from $8.8 billion in the prior quarter.
- Across five years, Total Current Liabilities topped out at $9.0 billion in Q3 2024 and bottomed at $6.6 billion in Q2 2024.
- Historically, Total Current Liabilities has averaged $7.6 billion across 5 years, with a median of $7.6 billion in 2022.
- Annual changes were most pronounced in 2023 — Total Current Liabilities decreased 14.98% — and 2024, when it soared 34.86%.
- Becton Dickinson's Total Current Liabilities stood at $7.6 billion in 2022, then dropped by 1.11% to $7.5 billion in 2023, then increased by 1.64% to $7.7 billion in 2024, then increased by 14.31% to $8.8 billion in 2025, then dropped by 2.9% to $8.5 billion in 2026.
- Business Quant data shows BDX's Total Current Liabilities at $8.5 billion in Q1 2026, $8.8 billion in Q4 2025, and $8.3 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 9.40 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 3.17 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 1.40 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 2.71 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 3.66 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 1.80 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 3.59 Bn |
| 10 | Align Technology | 11.37 Bn | 10.27 Bn | 757.43 Mn | 1.91 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.40 Bn |
| Mar 31, 2026 | 8.51 Bn |
| Dec 31, 2025 | 8.76 Bn |
| Sep 30, 2025 | 8.31 Bn |
| Jun 30, 2025 | 8.16 Bn |
| Mar 31, 2025 | 7.69 Bn |
| Dec 31, 2024 | 7.66 Bn |
| Sep 30, 2024 | 8.96 Bn |
| Jun 30, 2024 | 6.61 Bn |
| Mar 31, 2024 | 7.33 Bn |
| Dec 31, 2023 | 7.54 Bn |
| Sep 30, 2023 | 6.64 Bn |
| Jun 30, 2023 | 6.88 Bn |
| Mar 31, 2023 | 7.30 Bn |
| Dec 31, 2022 | 7.63 Bn |
| Sep 30, 2022 | 7.81 Bn |
| Jun 30, 2022 | 7.08 Bn |
| Mar 31, 2022 | 6.66 Bn |
| Dec 31, 2021 | 6.74 Bn |
| Sep 30, 2021 | 6.63 Bn |